Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Friedland

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Clinical Transplantation|August 1, 2023
Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipientsDavid M Newland, Jennifer L Pak, Reda Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumorsWilliam C Zamboni, Laura L Jung, Merrill J Egorin, et al.
Clinical Transplantation|May 29, 2024
Prevalence of iron deficiency and anemia in pediatric heart transplant recipientsDavid M Newland, Kathryn L Spencer, Long D Do, et al.
Cancer|May 5, 2017
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancerAhmad A Tarhini, Imran Rafique, Theofanis Floros, et al.
Circulation. Heart Failure|February 14, 2023
Considerations for Advanced Heart Failure Consultation in Individuals With Fontan Circulation: Recommendations From ACTIONAdam M Lubert, Ari Cedars, Christopher S Almond, et al.
Pediatric Transplantation|November 16, 2022
Fontan-associated liver disease after heart transplantEric R Griffiths, Linda M Lambert, Zhining Ou, et al.
Pediatric Cardiology|March 12, 2020
Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular DysfunctionMichael A McCulloch, Ashwin K Lal, Kenneth Knecht, et al.
Pediatric Cardiology|January 22, 2022
Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular DystrophyKatheryn E Gambetta, Michael A McCulloch, Ashwin K Lal, et al.
Progress in Pediatric Cardiology|July 31, 2019
Use of advanced heart failure therapies in Duchenne muscular dystrophyCarol A Wittlieb-Weber, Chet R Villa, Jennifer Conway, et al.
Pediatric Cardiology|February 5, 2020
Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular DystrophyCarol A Wittlieb-Weber, Kenneth R Knecht, Chet R Villa, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Clinical Transplantation|August 1, 2023
Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipientsDavid M Newland, Jennifer L Pak, Reda Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumorsWilliam C Zamboni, Laura L Jung, Merrill J Egorin, et al.
Clinical Transplantation|May 29, 2024
Prevalence of iron deficiency and anemia in pediatric heart transplant recipientsDavid M Newland, Kathryn L Spencer, Long D Do, et al.
Cancer|May 5, 2017
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancerAhmad A Tarhini, Imran Rafique, Theofanis Floros, et al.
Circulation. Heart Failure|February 14, 2023
Considerations for Advanced Heart Failure Consultation in Individuals With Fontan Circulation: Recommendations From ACTIONAdam M Lubert, Ari Cedars, Christopher S Almond, et al.
Pediatric Transplantation|November 16, 2022
Fontan-associated liver disease after heart transplantEric R Griffiths, Linda M Lambert, Zhining Ou, et al.
Pediatric Cardiology|March 12, 2020
Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular DysfunctionMichael A McCulloch, Ashwin K Lal, Kenneth Knecht, et al.
Pediatric Cardiology|January 22, 2022
Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular DystrophyKatheryn E Gambetta, Michael A McCulloch, Ashwin K Lal, et al.
Progress in Pediatric Cardiology|July 31, 2019
Use of advanced heart failure therapies in Duchenne muscular dystrophyCarol A Wittlieb-Weber, Chet R Villa, Jennifer Conway, et al.
Pediatric Cardiology|February 5, 2020
Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular DystrophyCarol A Wittlieb-Weber, Kenneth R Knecht, Chet R Villa, et al.
Pageof 10